The API Innovation Center's Gerren McHam on China's new supply chain rules, reshoring policy, and where US drug manufacturing goes next.
Gerren McHam
Advertisement
Gerren McHam is vice president, government and external affairs, at the API Innovation Center.
Articles by Gerren McHam
Gerren McHam of the API Innovation Center on what a resilient US pharmaceutical supply chain looks like in five to ten years, and what execution actually requires.
Gerren McHam of the API Innovation Center outlines what a whole-of-government approach to meaningful pharmaceutical supply chain independence from China actually requires.
China's 2026 supply chain rules mean routine US trade compliance can now trigger Chinese export restrictions.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Escalating Iran Standoff and Red Sea Attacks Raise Freight Risk for Pharma Supply Chains
2
FDA Launches Small Dispenser Assessment, Grants DSCSA Exemptions
3
Reshoring Update: BMS Commits $2.3B to Houston Campus
4
Health Plans, PBMs Wary of TrumpRx Impact on Patients
5